The oral quinine drops were prepared -Raman and NIR spectroscopy methods were developed and validated -The methods were applied for analysis the real and substandard drugs. Accuracy profiles. 28
Introduction 31
Malaria remains one of the most rampant illnesses worldwide and is one of the main 32 causes of child mortality in developing countries [1] [2] . The treatment of uncomplicated 33 malaria is based on conventional antimalarial drugs (e.g. chloroquine, artemisinin derivatives, 34 atovaquone, etc.). These drugs are essentially used as combinations due to the growing 35 resistance observed with single-drug therapy [3] . However, quinine is still recommended 36 alone in the treatment of severe and/or cerebral malaria attacks as well as for chloroquine-37 resistant falciparum malaria [4] . Four quinine based dosage forms are found on the 38 pharmaceutical market in DRC: tablets (250 and 500 mg), ampuls (250 and 500 mg/2mL), 39 syrup (100 mg /mL) and oral drops (200 mg /mL). The last three dosage forms are the most 40 used with 0-5 year old children. In 2009, the Health Ministry of the DRC warned citizens 41 against quinine oral drops "Quinizen 20%" that were found to have been counterfeit and 42 substandard [5] . 43
Poor quality (substandard, counterfeit and degraded) or substandard/spurious/falsely-44 labelled/falsified/counterfeit anti-malarial drugs constitute a major public health concern 45 especially in developing countries where the pharmaceutical market is poorly regulated and 46
The use such drugs may lead to therapeutic failure, death and reinforce drug resistance [7, 8] .
(Perkin Elmer, MA, USA) equipped with a two-dimensional CCD detector (1024 × 256 pixel 79 sensor). The laser excitation wavelength used was 785 nm with a power of 100 mW. Raman 80 spectra were collected with a Raman reflectance probe for solids and liquids interfaced with 81 Spectrum Software 6.3.2.0151 (Perkin Elmer). The spectral coverage was 3620-90 cm -1 with 82 a spectral resolution equal to 2 cm -1 . Each Raman spectrum resulted from the accumulation of 83 six spectra with a 5.0 s exposure time. NIR and Raman spectra were acquired on the same day 84 and prior to the analysis by HPLC-UV allowing the determination of the concentration of 85 quinine dihydrochloride corresponding to each sample. 86
Reference method 87
The HPLC experiments were performed on an Alliance 2695 HPLC system (Waters, 88
Milford, USA) coupled to a 2996 PDA detector (Waters). Data acquisition and treatment were 89 performed with the Empower 2 ® software (Waters). The analysis was performed with an 90 XBridge TM C18 (250 mm x 4.6 mm, 5µm particle size) column preceded by an XBridge TM C18 91 (20 mm x 4.6 mm, 5 µm particle size) guard column kept at 30°C. The mobile phase 92 
Preparation of solutions for HPLC analysis of samples 120
Two independent standard solutions were prepared by dissolving quinine dihydrochloride 121 in ultrapure water to achieve a final concentration of 100 µg mL -1 . Calibration, validation and 122 test samples were diluted in ultrapure water to obtain a final concentration of 100 µg mL -1 . 123
Preparation of calibration and validation samples for NIR and Raman 124
The target (100%) sample composition is 20% (W/V) quinine dihydrochloride dissolved 125 in an excipient solution composed of propylene glycol and benzoic acid in ultrapure water.q uinine dihydrochloride in the excipients solution to achieve concentrations of 50, 75, 100, 128 125 and 150% of the target amount. Three series of both calibration (C1, C2, C3) and 129 validation (V1, V2, V3) samples were prepared with three replicates for each concentration 130 level. C1, C2, V2 and V3 series were prepared using quinine dihydrochloride from 131 Pharmakina (Bukavu, DRC). While C3 and V1 series were prepared using quinine 132 dihydrochloride from A.V. Pharma (Kinshasa, DRC). 133
Multivariate data analysis 134
Partial Least Squares (PLS) regression models were built with NIR and Raman data using 135
HPLC assay values as reference. Several PLS models were built using different pre-136 processing methods. Best models were selected based on their Root Mean Square Error of 137 Prediction (RMSEP) computed as follows: 138
(1) 140
where is the reference value determined by HPLC, is the predicted value given by the 141 PLS model and is the total number of samples. All data were mean centered and the number 142 of latent variables of each PLS models was selected based on the RMSECV versus latent 143 variables plot. Cross validation consisted of random subsets with ten data splits and ten 144 iterations. First and second derivatives were computed using the Savitsky-Golay algorithm 145 [19] with a polynomial order of 2 and 15 smoothing points. Asymmetric Least Squares has 146 been used for baseline correction of Raman spectra. A value λ of 10 5 and a value p of 10 -3 147 were used. PLS models were built using PLS_Toolbox 7.0.3 (Wenatchee, WA, USA) running 148 on Matlab ® R2013a (The Mathworks, Natick, MA, USA). 149
The validation of a multivariate calibration model is often performed by checking at the 150 R² and RMSEP values. However, as described in De Bleye et al. [20] , these performance 151 parameters are not sufficient to ensure that the developed method will provide reliable resultso r the complete dosing range. Therefore, both NIR and Raman predictive models were 153 validated through the "total error" approach. All validation calculations were performed with 154 e-noval ® version 3.0 (Arlenda S.A., Liège, Belgium). 155
Results and discussion 156

Validation of the reference method 157
The method was successfully validated using the "total error" approach in the range of 50 158 µg mL -1 to 150 µg mL -1 with acceptance limits set at 10% according to the USP for quinine 159 sulphate tablet assay [21] . Trueness, precision (repeatability and intermediate precision), 160 accuracy and linearity of the method were found to be acceptable (see also Table 1) . 161
Quantitative NIR study 162
Quantifying an API in an aqueous matrix may be a difficult task with NIR spectroscopy. 163
Indeed, the matrix absorbance spectrum shows that the multiple absorption maxima 164 characteristic of water and detector saturation occurs between 5250 and 5050 cm -1 . Therefore, 165 the spectral range was selected between 8937-7278, 6318-5396 and 4733-4428 cm -1 to build 166 PLS models (see Figure 1a) . By doing so, perturbations due to matrix absorptions were 167 avoided while keeping the information dealing with the API. Table 2 
uture analysis of unknown samples. As 178 can be determined from the accuracy profile (Figure 2b) , the β-expectation tolerance intervals 179 of each concentration level are inside the limits of acceptation set at 10%. This indicates that 180 95% of future measurements will lie within these limits. The largest β-expectation tolerance 181 intervals have relative values of -5.84% and 6.57% (see Table 1 ). 182
Quantitative Raman Study 183
Compared to NIR spectroscopy, the main advantage of Raman spectroscopy in 184 quantifying an API in an aqueous matrix is due to the weak Raman scattering effect of water. 185
Raman spectroscopy, however is often limited to pharmaceutical applications due to the 186 fluorescence of samples. The spectral range was selected to be 1720-306 cm -1 to build PLS 187 models. The selected model was the one obtained by applying baseline correction by 188 asymmetric least squares (AsLS) with a RMSEP of 1.88% and two latent variables (see 189 Figure 1b ). As can be seen in Figure 2a and water 79% (W/V), whereas the excipients are less than 1% (W/V). The spectral variations 211 due to differences in qualitative composition were below the detection limits of both 212 techniques thus did not allow a distinction between the manufacturers. Test samples were then 213 analyzed with the two developed PLS models. As shown in Table 3 antimalarial drugs based on a generic approach, using design of experiments, 
